Evidence map›Paper›PMID 34330701›Full record

ArticleScience advances2021

FAN1-MLH1 interaction affects repair of DNA interstrand cross-links and slipped-CAG/CTG repeats.

Antonio Porro, Mohiuddin Mohiuddin, Christina Zurfluh, Vincent Spegg, Jingqi Dai, Florence Iehl, Virginie Ropars, Giulio Collotta, Keri M Fishwick, Nour L Mozaffari and 6 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Emerging drivers of DNA repeat expansions.Biochemical Society transactions · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Posttranscriptional regulation ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Antonio PorroInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-2131-7771
Mohiuddin MohiuddinProgram of Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.ORCID 0000-0003-1899-6734
Christina ZurfluhInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Vincent SpeggDepartment of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.
Jingqi DaiUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.ORCID 0000-0001-6294-8524
Florence IehlUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.
Virginie RoparsUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.ORCID 0000-0002-3372-6030
Giulio CollottaInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-0661-1905
Keri M FishwickInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Nour L MozaffariInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-4129-7459
Raphaël GuéroisUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.ORCID 0000-0001-5294-2858
Josef JiricnyInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Matthias AltmeyerDepartment of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.
Jean-Baptiste CharbonnierUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.ORCID 0000-0002-5219-1983
Christopher E PearsonProgram of Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada. cepearson.sickkids@gmail.com sartori@imcr.uzh.ch.ORCID 0000-0001-9545-4205
Alessandro A SartoriInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland. cepearson.sickkids@gmail.com sartori@imcr.uzh.ch.ORCID 0000-0003-2770-0333
University of Zurich · CHCentre National de la Recherche Scientifique · FRHospital for Sick Children · CAUniversity of Toronto · CA

Funding

European Research Council 714326
6 · The paper itself

Abstract

FAN1, a DNA structure-specific nuclease, interacts with MLH1, but the repair pathways in which this complex acts are unknown. FAN1 processes DNA interstrand crosslinks (ICLs) and FAN1 variants are modifiers of the neurodegenerative Huntington's disease (HD), presumably by regulating HD-causing CAG repeat expansions. Here, we identify specific amino acid residues in two adjacent FAN1 motifs that are critical for MLH1 binding. Disruption of the FAN1-MLH1 interaction confers cellular hypersensitivity to ICL damage and defective repair of CAG/CTG slip-outs, intermediates of repeat expansion mutations. FAN1-S126 phosphorylation, which hinders FAN1-MLH1 association, is cell cycle-regulated by cyclin-dependent kinase activity and attenuated upon ICL induction. Our data highlight the FAN1-MLH1 complex as a phosphorylation-regulated determinant of ICL response and repeat stability, opening novel paths to modify cancer and neurodegeneration.

Indexed as

EndodeoxyribonucleasesExodeoxyribonucleasesDNADNA DamageMultifunctional EnzymesDNAEndodeoxyribonucleasesExodeoxyribonucleasesMultifunctional Enzymes

Identifiers

PMID34330701
PMCPMC8324060
OpenAlexW3184733628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.